Uploaded October 2025 | Updated September 2026, 2 weeks ago
Join Dr. Boro Dropulić, pioneering scientist and biotechnology innovator, as he takes us through his groundbreaking journey in the field of gene and cell therapy. With decades of experience and a career spanning academia, entrepreneurship, and clinical innovation, Dr. Boro has been instrumental in shaping the future of genetic medicine. From developing the first safe Lentiviral vectors in humans to contributing to the creation of Kymriah®—the first FDA-approved gene therapy—his work continues to redefine the possibilities of curative treatments. In this insightful segment, Dr. Boro shares how innovation, collaboration, and purpose are driving the next generation of accessible and transformative cell-based therapies.
🔗 Stay Connected:
Buy a Copy of My New Book UNDUSRUPTED amzn.to/4g5gjH9
Visit my website: iankhan.com
Follow me on Twitter: twitter.com/IanKhanFuturist
Follow me on LinkedIn: linkedin.com/in/iankhanfuturist
Follow me on Facebook: facebook.com/iankhanfuturist
Join Dr. Boro Dropulić, pioneering scientist and biotechnology innovator, as he takes us through his groundbreaking journey in the field of gene and cell therapy. With decades of experience and a career spanning academia, entrepreneurship, and clinical innovation, Dr. Boro has been instrumental in shaping the future of genetic medicine. From developing the first safe Lentiviral vectors in humans to contributing to the creation of Kymriah®—the first FDA-approved gene therapy—his work continues to redefine the possibilities of curative treatments. In this insightful segment, Dr. Boro shares how innovation, collaboration, and purpose are driving the next generation of accessible and transformative cell-based therapies.
🔗 Stay Connected:
Buy a Copy of My New Book UNDUSRUPTED amzn.to/4g5gjH9
Visit my website: iankhan.com
Follow me on Twitter: twitter.com/IanKhanFuturist
Follow me on LinkedIn: linkedin.com/in/iankhanfuturist
Follow me on Facebook: facebook.com/iankhanfuturist










